1. Academic Validation
  2. Chemerin 15 enhances microglial phagocytosis to attenuate cerebral ischemia-reperfusion injury through the ChemR23/p38 MAPK pathway

Chemerin 15 enhances microglial phagocytosis to attenuate cerebral ischemia-reperfusion injury through the ChemR23/p38 MAPK pathway

  • iScience. 2025 Aug 19;28(9):113396. doi: 10.1016/j.isci.2025.113396.
Yuhan Yang 1 2 3 Yan Huang 1 2 Jun Li 1 2 Kunyi Li 1 2 Changhao Mao 1 4 Gang Liu 1 4 Shuang Li 1 2 Lan Wen 1 2
Affiliations

Affiliations

  • 1 School of Clinical Medicine, Chengdu Medical College, Chengdu 610500, P.R. China.
  • 2 Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, P.R. China.
  • 3 Department of Neurology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, China.
  • 4 Department of Neurosurgery, The First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, P.R. China.
Abstract

Microglia recover and maintain homeostasis in the central nervous system by phagocytosing dead cells and harmful substances under pathological conditions. Chemerin 15 (C15), a chemerin-derived peptide, is an endogenous phagocytic and inflammatory regulator that acts via the G protein-coupled receptor, ChemR23. However, the effect of C15 on microglial phagocytosis following ischemia-reperfusion injury remains unclear. Here, we found that microglial phagocytosis was activated and dynamically altered after ischemia-reperfusion injury. C15 administration promoted microglial phagocytosis of bioparticles and neuronal debris and upregulated the phagocytosis-related genes and pathways. Furthermore, C15 binding to ChemR23 decreased damage-associated molecular patterns (DAMPs) and ROS production and further alleviated the infarct volume and neurological deficits after ischemia-reperfusion injury. Thus, C15 is a potential therapeutic target for the recovery of neurological function after stroke.

Keywords

Cell biology; Molecular biology; Neuroscience; Pharmacology.

Figures
Products